I dont have thoughts either way. Perhaps because
Post# of 148170
(Total Views: 466)
Posted On: 01/13/2021 12:09:32 PM
Re: craigakess #72544
I dont have thoughts either way. Perhaps because its not a concern for me, but perhaps because I dont think it is for them either.
I know it could be beneficial to have the uplist complete to capitalize on the EUA assuming we get it, but I think they are 100% focused on the trial data.
If they get it done, great. But, I have been in a few other companies that have uplisted and I think the effect of this has been exaggerated.
I know it could be beneficial to have the uplist complete to capitalize on the EUA assuming we get it, but I think they are 100% focused on the trial data.
If they get it done, great. But, I have been in a few other companies that have uplisted and I think the effect of this has been exaggerated.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼